FDA Inspection
Shandong Xinhua Pharmaceutical Company LimitedShandong Xinhua Pharmaceutical Company Limited – FDA Inspection, Mar 29, 2019
Record Details
This FDA Inspection record concerns Shandong Xinhua Pharmaceutical Company Limited, with an inspection on March 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 92338ae1-9f91-46e4-bd2c-776ae27f2a10
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1087221
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Xinhua Pharmaceutical Company Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 5, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong Xinhua Pharmaceutical Company Limited
- FDA Inspection 1237492 - 2024-04-05
- FDA Inspection 997761 - 2016-03-31
- FDA Inspection 876774 - 2014-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.